Charles Schwab Investment Management Inc Tarsus Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 290,009 shares of TARS stock, worth $15.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
290,009
Previous 261,879
10.74%
Holding current value
$15.7 Million
Previous $7.12 Million
34.02%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$184 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$177 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$132 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$122 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$119 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.44B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...